OraSure Technologies, Inc. stock is up 16.05% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40.62% of the previous 31 December’s closed higher than November. 0% of analysts rate it a buy.
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. It operates in two segments, Diagnostics and Molecular Solutions. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities.